AI filing briefs · archive
Every 8-K brief, with filters
The whole archive: 33,711 AI briefs of material SEC Form 8-K filings by 4,788 companies: 2,325 written within three weeks of the filing (filed since Oct 19, 2026) and 31,386 written later, for past filings. Pick a month, or filter by date, 8-K item, tone, impact, topic or ticker.
Briefs on record33,711every one kept
Companies4,788with at least one brief
Recent filings2,325filed since Oct 19, 2026
Past filings31,386written later, in Nov 2026
TechPrecision and its subsidiaries Ranor and Stadco entered a $10.0 million credit agreement with Rosenthal & Rosenthal on November 3, 2026, and used the proceeds to repay the prior Beacon Bank & Trust loan agreement. The facility includes a revolving line of up to $5.0 million and two term loans, and it requires a minimum quarterly tangible net worth of $5.5 million. The company also said it may be unable to file its Form 10-Q for the period ended September 30, 2026 on time.
- Facility includes a $5.0 million revolving line, a $1.5 million three-year term loan and a $3.5 million five-year term loan, secured by substantially all personal property and a first mortgage on Ranor's Westminster, Massachusetts facility
- Prior Beacon Bank & Trust loan agreement was terminated and repaid in full on November 3, 2026; closing costs were approximately $0.6 million.
- Company issued 25,000 shares of common stock to the broker that introduced the lender.
- Management expects the financing to alleviate the substantial doubt about going concern; tangible net worth was $7.6 million as of June 30, 2026 against the $5.5 million covenant.
Read the filing on SEC.gov ↗
On November 6, 2026, U.S. GoldMining agreed to sell 408,163 common shares at $4.90 each to an institutional investor in a registered direct offering. Gross proceeds are expected to be about $2.0 million before offering expenses, with closing expected on or about November 9, 2026. The company plans to use the net proceeds for working capital and general corporate purposes.
- Shares offered: 408,163 common shares at $4.90 per share
- Expected gross proceeds: approximately $1,999,998.70 before offering expenses
- Offering made under an effective Form S-3 shelf registration (File No. 333-279435) and a prospectus supplement dated November 6, 2026
- Expected closing on or about November 9, 2026, subject to customary conditions
Read the filing on SEC.gov ↗
UWM Holdings Corporation announced the final subscription price for its rights offering of up to 200,000,000 Class A common shares: $2.00 per share. The price is the greater of $2.00 and 85% of the 10-day volume-weighted average NYSE sales price ending November 9, 2026, so the $2.00 floor applied. Subscription rights expire at 5:00 p.m. Eastern Time on November 12, 2026, unless extended.
- Final subscription price is $2.00 per share, the greater of $2.00 and 85% of the 10-day volume-weighted average price ending November 9, 2026.
- The rights offering covers up to 200,000,000 shares of Class A common stock.
- Subscription rights expire at 5:00 p.m. Eastern Time on November 12, 2026, unless extended.
- Exercised rights can be withdrawn until 5:00 p.m. Eastern Time on November 10, 2026, unless the offering is extended; the company may amend, withdraw or terminate the offering with consent of the Backstop Purchasers.
Read the filing on SEC.gov ↗
American Tower priced three registered senior unsecured note offerings totaling $1.5 billion on November 9, 2026. The notes are fungible with existing notes issued on September 14, 2026, and expected net proceeds are $1,474.9 million, which the company intends to use to repay borrowings under its $6.0 billion revolving credit facility and for general corporate purposes.
- 2031 notes: $450.0 million at a 5.300% interest rate, priced at 99.387% of face value
- 2033 notes: $500.0 million at a 5.560% interest rate, priced at 99.369% of face value
- 2036 notes: $550.0 million at a 5.750% interest rate, priced at 98.986% of face value
- Expected net proceeds of $1,474.9 million, to repay revolver borrowings and for general corporate purposes
Read the filing on SEC.gov ↗
On November 9, 2026, Humana Inc. announced cash tender offers for eight series of its outstanding senior notes, with an aggregate purchase cap of $1.5 billion excluding accrued coupon payments. The offers expire at 5:00 p.m. New York City time on November 16, 2026, with settlement expected November 18, 2026. The filing is a debt management action and does not state its effect on earnings or guidance.
- Aggregate purchase cap of $1.5 billion, excluding accrued coupon payments, subject to proration and acceptance priority levels
- Series cap of $800 million on the 5.375% Senior Notes due 2031
- Offers expire 5:00 p.m. New York City time on November 16, 2026; pricing is set on the same day at 3:00 p.m.
- Expected settlement date is November 18, 2026; dealer managers include Barclays, BofA Securities, PNC and U.S. Bancorp
Read the filing on SEC.gov ↗
On November 9, 2026, Equinix Europe 2 Financing Corporation, an indirect wholly-owned subsidiary, issued €2.5 billion of senior notes in four series, fully and unconditionally guaranteed by Equinix, Inc. The notes carry fixed coupons from 4.150% to 5.450% and mature between 2028 and 2038, and Equinix intends to allocate the proceeds to eligible green projects. For shareholders, this adds debt to the company's balance sheet, though the filing does not compare it with existing debt levels.
- €650 million 4.150% notes due November 9, 2028, and €700 million 4.800% notes due February 15, 2033
- €500 million 5.100% notes due November 9, 2035, and €650 million 5.450% notes due November 9, 2038
- Net proceeds are intended for eligible green projects; pending allocation, they may be held in cash or used to repay existing borrowings
- Equinix hedged part of the interest rate risk on the 2035 and 2038 notes, with effective all-in rates of 4.91% and 5.42%
Read the filing on SEC.gov ↗
Orchestra BioMed sold 15,000,000 shares of common stock at $5.00 per share under an underwritten public offering priced November 5, 2026, and the offering closed November 9, 2026. The underwriters' 2,250,000-share option was exercised in full on November 6, 2026, and the filing puts gross proceeds at approximately $86.3 million before underwriting discounts and expenses, with the company citing the AVIM Therapy program, the BACKBEAT pivotal trial, and the Virtue SAB program as intended uses.
- Offering: 15,000,000 shares at $5.00 per share, priced November 5, 2026, with Piper Sandler and TD Securities as representatives of the underwriters
- Underwriters' 30-day option for 2,250,000 additional shares was exercised in full on November 6, 2026
- Gross proceeds of approximately $86.3 million before underwriting discounts, commissions and other offering expenses; offering closed November 9, 2026
- Stated uses: AVIM Therapy program, BACKBEAT global pivotal trial, Virtue SAB program and its coronary in-stent restenosis trial, other product candidates, and working capital
Read the filing on SEC.gov ↗
Texas Instruments completed the sale of $2 billion of senior notes on November 9, 2026, split into four $500 million tranches maturing in 2028, 2031, 2033 and 2036. The filing is a debt financing that adds to the company's borrowings, and it sets coupons of 5.000% to 5.750%, which shareholders may weigh against the cost of that debt.
- Four $500 million tranches: 5.000% notes due 2028, 5.350% due 2031, 5.500% due 2033 and 5.750% due 2036
- Sold under an underwriting agreement dated October 26, 2026 with J.P. Morgan Securities LLC, Citigroup Global Markets Inc., BofA Securities, Inc. and U.S. Bancorp Investments, Inc. as representatives
- Issued under a 2011 indenture with U.S. Bank Trust Company, National Association, as trustee, and offered under a Form S-3 filed February 14, 2025
Read the filing on SEC.gov ↗
On November 9, 2026, CRH America Finance, a wholly owned subsidiary of CRH plc, completed the sale of four series of U.S. dollar guaranteed notes, fully guaranteed by CRH plc, with principal amounts totaling $4.2 billion. The company said net proceeds are expected to fund tender offers for outstanding Arcosa, Inc. notes, repay existing debt and support general corporate purposes, which adds to CRH's debt obligations while refinancing and reshaping its borrowings.
- Four series issued: $1.35 billion 5.375% notes due 2032, $1.0 billion 5.625% notes due 2034, $1.35 billion 5.750% notes due 2037, and $500 million 6.250% notes due 2057
- Notes were sold under an underwriting agreement dated November 4, 2026, with Barclays Capital, J.P. Morgan Securities and Morgan Stanley as representatives
- Net proceeds are expected to finance tender offers for Arcosa, Inc. notes, repay existing debt and fund general corporate purposes
Read the filing on SEC.gov ↗
SS&C Technologies completed a private offering of $1.2 billion of 2.75% convertible senior notes due December 1, 2031, including a $150 million option exercised in full by the initial purchasers. The company plans to use the proceeds for capped call transactions, share repurchases of about $100 million, and redeeming its $2.0 billion of 5.500% Senior Notes due 2027, which adds debt and creates potential dilution if the notes convert.
- Notes issued November 6, 2026 under an indenture with Wilmington Trust, National Association, as trustee, bearing interest at 2.75% payable June 1 and December 1.
- Initial conversion price of about $99.46 per share, a premium of about 25.0% over the $79.57 closing price on November 4, 2026.
- Proceeds planned for about $99 million capped call cost, about $100 million of share repurchases (about 1.3 million shares), and redemption of the $2,000.0 million 2027 Senior Notes.
- Company may not redeem the notes before December 5, 2029, except in a cleanup redemption.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.